---
title: "Abbott’s Tendyne TMVR system gains US FDA approval"
date: "2025-05-27T16:35:16.000Z"
publishedDate: "27 mai 2025"
summary: "Abbott has announced US Food and Drug Administration (FDA) approval for its Tendyne transcatheter mitral valve replacement (TMVR) system to treat people with mitral valve disease. The therapy is available for patients whose mitral valves are not functioning properly due to severe mitral annular calcification (MAC)."
importance: ""
sourceUrl: "https://cardiovascularnews.com/abbotts-tendyne-tmvr-system-gains-us-fda-approval/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-05-27-abbotts-tendyne-tmvr-system-gains-us-fda-approval"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2018/07/Abbott_Tendyne-valve_facing-33-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/abbotts-tendyne-tmvr-system-gains-us-fda-approval/"
---

![Abbott’s Tendyne TMVR system gains US FDA approval](https://cardiovascularnews.com/wp-content/uploads/sites/14/2018/07/Abbott_Tendyne-valve_facing-33-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/abbotts-tendyne-tmvr-system-gains-us-fda-approval/*

## L’essentiel

Abbott has announced US Food and Drug Administration (FDA) approval for its Tendyne transcatheter mitral valve replacement (TMVR) system to treat people with mitral valve disease. The therapy is available for patients whose mitral valves are not functioning properly due to severe mitral annular calcification (MAC).

## Lien source

https://cardiovascularnews.com/abbotts-tendyne-tmvr-system-gains-us-fda-approval/
